JAZZ Financial Facts
Research and development: 47.8MNet income (loss): 87.15M
See Full Income Statement
See Full Balance Sheet
Jazz Pharmaceuticals, Inc. (JAZZ) Earnings
|
Expand Research on JAZZ
| Next EPS Date | 5/7/24 | EPS Growth Rate | +6.3% |
|---|---|---|---|
| Average EPS % Beat Rate | -2.6% | Revenue Growth Rate | +7.2% |
| Average % Move 1-Wk after EPS | -2.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/10  |
 |
Q310 | $0.41 | $0.34 | +$0.07 | N/A | N/A | N/A |  | | Details |
| 3/7/11 | |
Q410 | $0.63 | $0.60 | +$0.03 | $53.4M | $51.05M |  |
| | Details |
| 3/1/22 | |
Q421 | $4.21 | $3.63 | +$0.58 | $892.88M | $865.88M | |
| | Details |
| 8/4/20 | |
Q220 | $3.71 | $3.11 | +$0.60 | $562.4M | $504.65M | |
| | Details |
| 5/8/18 | |
Q118 | $2.98 | $2.77 | +$0.21 | $444.61M | $434.87M | = | | | Details |
| 11/5/13 |
|
Q313 | $1.78 | $1.67 | +$0.11 | $232.2M | $227.38M | = | | | Details |
| 5/4/21 | |
Q121 | $3.92 | $3.71 | +$0.21 | $607.58M | $608.24M | = | | | Details |
| 2/26/19 | |
Q418 | $3.64 | $3.02 | +$0.62 | $476.5M | $459.72M | |
| | Details |
